NCT07794670: Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease
- State
- Under way
- Phase
- Phase 2
- People
- 400 planned
- Started
- Sep 2026
- Primary completion
- Sep 2028
- Arms
- Obicetrapib
- Results
- None posted
- 31 Aug 2026: Trial registered